{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-316225","form_type":"8-K","ticker":"RNTX","cik":"0001420565","company_name":"Rein Therapeutics, Inc.","filed_at":"2025-12-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.369983+00:00","generated_at":"2026-05-16T13:29:10.464467+00:00","sec_items":["1.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Rein Therapeutics terminates Yorkville equity facility; $3M drawn, no penalties","bullets":["Terminated Pre-Paid Advance and Standby Equity Purchase Agreements with Yorkville on Dec 11, 2025.","Total $3M in advances drawn under PPA; most recent advance on Oct 23, 2025.","No sales of common stock executed under the Standby Equity Purchase Agreement.","No penalties or fees incurred in connection with the termination."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-316225","json":"https://secwatch.observer/filing/0001193125-25-316225.json","markdown":"https://secwatch.observer/filing/0001193125-25-316225.md","text":"https://secwatch.observer/filing/0001193125-25-316225.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1420565/000119312525316225/0001193125-25-316225-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1420565/000119312525316225/d783815d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T13:29:10.464467+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}